Coronary Drug Eluting Stents With (1) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. (2) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intimal Hyperplasia)

Sharing tender

Supply Of , Coronary Drug Eluting Stents With (1) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. (2) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo- Intimal Hyperplasia) (3) Stent Diameter Should Be From 2.5Mm To 4Mm . The Length Of The Stent Should Be More Than 38Mm . (4) The Strut Thickness Should Be 91 Micron Or Less. (5) Stent Delivery System Should Be Monorail (Single Operator Exchange Or Rapid Exchange). (6) Stent Should Be Compatible With 5Fr Guiding Catheter (7) Stent Design Should Be Open Cell Type. (8) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid / Offer. (9) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis (Isr) And In-Situ Thrombosis (Ist) Should Be Documented / Published In Peer Reviewed Scientific Journals. (10)The Manufacturer/Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.Bis Standards For The Drug Eluting Stent Are Not Available (Reference : Bis Catalogue ) Unit:No